Interest rates have increased but the official cash rate has not. The cost of funding for banks has increased and this squeeze is passed on to the borrower.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025